Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-036475)

Filing Details

Accession Number:: 0001181431-11-036475
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-06-14 13:50:03
Reporting Period:: 2011-06-10

Filing Date:: 2011-06-14
Accepted Time:: 2011-06-14 13:50:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389870	Omni Bio Pharmaceutical Inc.	OMBP	Biological Products, (No Disgnostic Substances) (2836)	208097969

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295287	Cecil Robert Ogden	5350 South Roslyn Suite 430 Greenwood Village CO 80111	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-10	10,000	$0.00	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Buy)	Acquisiton	2011-06-10	10,000	$0.00	10,000	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2011-06-10	2016-06-10	No	4	P	Direct

Footnotes

The reporting person purchased 10,000 Units from the issuer in a private placement transaction for $1.25 per Unit. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.